Here you can find out the latest news and announcements at Pathfinder Therapeutics, Inc. including events and product release information.
Pathfinder Therapeutics has finalized a clinical trial agreement with Robert Martin, M.D., at the University of Louisville Medical Center evaluating the utility of the Pathfinder technology for irreversible electroporation (IRE) procedures on the pancreas and liver. Dr. Martin is the Sam and Lolita Weakley Professor of Surgery at University of Louisville and Division Director of Surgical Oncology. He has completed fellowships in Surgical Oncology and Hepatobiliary Surgery at Memorial Sloan-Kettering Cancer Center. In collaboration with Pathfinder clinical representatives, Dr.Martin will utilize Scout pre-operative planning software to generate 3-dimensional models of the organ, vessels, and lesion(s). Intra-operatively, the Pathway guidance software will optically track the IRE needle and aid in the localization of lesion(s). Additionally, Dr. Martin will utilize a modified version of the Pathfinder Shadow instrument, using it to track an ultrasound finger probe transducer.